Who benefits from consolidation durvalumab in stage III non-small cell lung cancer? De Ruysscher D, Remon J, Hendriks LEL. Eur J Cancer 2022 Mar 17. pii: S0959-8049(22)00107.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Ruysscher D, Remon J, Hendriks LEL. Who benefits from consolidation durvalumab in stage III non-small cell lung cancer? Eur J Cancer 2022 Mar 17. pii: S0959-8049(22)00107.
PMID: 35307255